Contrast Media Market Analysis North America, Europe, APAC, South America, Middle East and Africa - US, Japan, China, Germany, UK - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 175 SKU: IRTNTR75518

Contrast Media Market Forecast 2023-2027

The contrast media market size is forecast to increase by USD 946.31 Million between 2022 and 2027, accelerating at a CAGR of 3.36%. In 2017, the US held the largest market share, projecting an annual revenue of USD 1,122 Million. In recent years, there has been a significant increase in medical spending in various countries. This boost in medical expenses is expected to help the global contrast media market grow even more. The report provides market size, historical data spanning from 2017 to 2021, and future projections, all presented in terms of value in (USD Million) for each of the mentioned segments.

What will be the Size of the Contrast Media Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Overview 

The rise in healthcare spending is the key factor driving the growth of the global market. In recent years, there has been a significant increase in medical spending in various countries, which is expected to contribute to the global market. For instance, with the increase in disposable income, the spending on healthcare facilities is expected to increase, which, in turn, will drive the demand for contrast media in various diagnostic imaging during the forecast period.

For instance, in 2022, healthcare spending accounted for 18.3% of the US gross domestic product (GDP), higher than 17.6% in 2019. Also, healthcare expenditure is increasing in various nations, such as India and Brazil. Thus, the growing healthcare expenditure will significantly drive the adoption of advanced medical facilities. Therefore, the increase in healthcare spending by countries to enhance the healthcare infrastructure, meet the growing demands of patients, and offer advanced medical treatment is likely to drive the growth of the market during the forecast period.

Market Segment Trends

The market share growth by the X-ray/CT segment will be significant during the forecast period. The growing prevalence of chronic conditions such as cancer and CVD has increased the procedure volumes of X-ray/CT scan examinations across the world. In addition, iodine-based contrast media was injected into a vein (intravenously) to enhance X-ray visibility (including fluoroscopic images). Various vendors, such as GE Healthcare and Bayer, offer contrast media for X-ray /CT scans. Furthermore, the increasing X-rays/CT scans will drive the demand for contract media, thereby driving market growth during the forecast period.

Market  - Revenue Share by Modality Segment, 2017 - 2021 - 2027.   

For more details on other segments, Download Sample Report 

The X-ray/CT segment was valued at USD 3,275.96 million in 2017 and continued to grow until 2021. The global X-ray systems segment is currently in a high-growth phase and is expected to remain the same during the forecast period. The market has substantially benefitted from the increasing adoption of digital radiography (DR) systems in developed regions such as North America and Europe. The increase in the adoption of DR systems can be attributed to the demand for digital X-ray systems, which is primarily driven by the growing need for the diagnosis of chronic diseases, such as cancer and spinal disorders. CT scan provides several X-ray images to generate cross-sectional views of internal organs and structures of the body. It enables physicians to accurately diagnose and treat chronic diseases such as cancer, neurological disorders, and cardiovascular diseases. Such factors will increase segment growth during the forecast period.

Regional Analysis

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In this region, government and non-profit organizations are creating awareness regarding the need for the early diagnosis of chronic diseases, including lung cancer, breast cancer, and cardiovascular diseases, in the region. Various institutions, such as the Centers for Disease Control and Prevention (CDC) and the Canadian Cancer Society, are creating awareness regarding the need for regular breast cancer screening.

For instance, the CDC conducts the National Breast and Cervical Cancer Early Detection Program, under which it provides breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underserved women. Such initiatives are expected to increase the demand for diagnostic procedures for chronic diseases such as cancer and, in turn, will drive the growth of the regional market during the forecast period.

Market Size, By Region, Global, 2017 - 2027.   

To understand geographic trends Download Report Sample

Companies Overview

This market is fragmented in nature. Some significant players include Bayer AG, Beijing Beilu Pharmaceutical Co. Ltd., Blue Jet Healthcare Ltd., Bracco Spa.

This market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Covis Pharma GmbH, GE Healthcare Technologies Inc., Guerbet, iMAX Diagnostic Imaging Ltd., Interpharma Praha as, JB Chemicals and Pharmaceuticals Ltd.,  Jodas Expoim Pvt. Ltd., Lantheus Holdings Inc., Livealth Biopharma Pvt. Ltd., M.Biotech Ltd., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Taejoon Pharm Co. Ltd., and Unijules Life Sciences Ltd.

Market Analyst Overview

The Contrast Media Market is vital for various medical procedures, including Outpatient treatments and Image-guided procedures. It facilitates Diagnostics for conditions like Pulmonary embolism and Cancer diagnosis, distinguishing between Malignant and Benign tissues. Important entities like the Medicare Payment Advisory Commission (MedPAC) and the Center for Medicare and Medicaid Services (CMS) influence market dynamics.

Image-guided surgeries (IGS) rely on contrast agents for enhanced visualization of Vascular structures during Image-guided surgeries. The market encompasses various types of contrast media, including Iodinated Contrast Media and Ionic contrast media, utilized in Chest CT scans and Radiographic procedures. These media contain Tri-iodinated benzene rings and exhibit specific Imaging characteristics crucial for accurate diagnosis and treatment planning.

Segment Overview

This market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2021 - 2027.   

  • Modality Outlook (USD Million, 2017 - 2027)
    • X-ray/CT
    • MRI
    • Ultrasound
  • Application Outlook (USD Million, 2017 - 2027)
    • Neurological disorders
    • Cardiovascular disorders
    • Cancer
    • Gastrointestinal disorders
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • South America
      • Chile
      • Argentina
      • Brazil
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Contrast Media Market Scope

Report Coverage

Details

Page number

175

Base year

2022

Historic period

2017 - 2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 3.36%

Market growth 2023-2027

USD 946.31 Million

Market structure

Fragmented

YoY growth 2022-2023(%)

2.95

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 44%

Key countries

US, Japan, China, Germany, and UK

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Bayer AG, Beijing Beilu Pharmaceutical Co. Ltd., Blue Jet Healthcare Ltd., Bracco Spa, Covis Pharma GmbH, GE Healthcare Technologies Inc., Guerbet, iMAX Diagnostic Imaging Ltd., Interpharma Praha as, JB Chemicals and Pharmaceuticals Ltd.,  Jodas Expoim Pvt. Ltd., Lantheus Holdings Inc., Livealth Biopharma Pvt. Ltd., M.Biotech Ltd., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Taejoon Pharm Co. Ltd., and Unijules Life Sciences Ltd.

Market dynamics

Market trends, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2023 and 2027
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Market growth analysis across North America, Europe, APAC, South America, and Middle East and Africa
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Market forecasting of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Modality
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global contrast media market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global contrast media market 2017 - 2021 ($ million)
    • 4.2 Modality Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Modality Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Modality

    • 6.1 Market segments
      • Exhibit 30: Chart on Modality - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Modality - Market share 2022-2027 (%)
    • 6.2 Comparison by Modality
      • Exhibit 32: Chart on Comparison by Modality
      • Exhibit 33: Data Table on Comparison by Modality
    • 6.3 X-ray/CT - Market size and forecast 2022-2027
      • Exhibit 34: Chart on X-ray/CT - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on X-ray/CT - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on X-ray/CT - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on X-ray/CT - Year-over-year growth 2022-2027 (%)
    • 6.4 MRI - Market size and forecast 2022-2027
      • Exhibit 38: Chart on MRI - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on MRI - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on MRI - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on MRI - Year-over-year growth 2022-2027 (%)
    • 6.5 Ultrasound - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Ultrasound - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Ultrasound - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Ultrasound - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Ultrasound - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Modality
      • Exhibit 46: Market opportunity by Modality ($ million)
      • Exhibit 47: Data Table on Market opportunity by Modality ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 48: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 50: Chart on Comparison by Application
      • Exhibit 51: Data Table on Comparison by Application
    • 7.3 Neurological disorders - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Neurological disorders - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Neurological disorders - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Neurological disorders - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Neurological disorders - Year-over-year growth 2022-2027 (%)
    • 7.4 Cardiovascular disorders - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Cardiovascular disorders - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Cardiovascular disorders - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Cardiovascular disorders - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Cardiovascular disorders - Year-over-year growth 2022-2027 (%)
    • 7.5 Cancer - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Cancer - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
    • 7.6 Gastrointestinal disorders - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
    • 7.7 Others - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.8 Market opportunity by Application
      • Exhibit 72: Market opportunity by Application ($ million)
      • Exhibit 73: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 APAC - Market size and forecast 2022-2027
      • Exhibit 87: Chart on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on APAC - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on APAC - Year-over-year growth 2022-2027 (%)
    • 9.6 South America - Market size and forecast 2022-2027
      • Exhibit 91: Chart on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on South America - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on South America - Year-over-year growth 2022-2027 (%)
    • 9.7 Middle East and Africa - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • 9.8 US - Market size and forecast 2022-2027
      • Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.9 Japan - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 UK - Market size and forecast 2022-2027
      • Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 119: Market opportunity by geography ($ million)
      • Exhibit 120: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 121: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 123: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 124: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 125: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 126: Matrix on vendor position and classification
            • 12.3 Bayer AG
              • Exhibit 127: Bayer AG - Overview
              • Exhibit 128: Bayer AG - Business segments
              • Exhibit 129: Bayer AG - Key news
              • Exhibit 130: Bayer AG - Key offerings
              • Exhibit 131: Bayer AG - Segment focus
            • 12.4 Beijing Beilu Pharmaceutical Co. Ltd.
              • Exhibit 132: Beijing Beilu Pharmaceutical Co. Ltd. - Overview
              • Exhibit 133: Beijing Beilu Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 134: Beijing Beilu Pharmaceutical Co. Ltd. - Key offerings
            • 12.5 Bracco Spa
              • Exhibit 135: Bracco Spa - Overview
              • Exhibit 136: Bracco Spa - Product / Service
              • Exhibit 137: Bracco Spa - Key offerings
            • 12.6 Covis Pharma GmbH
              • Exhibit 138: Covis Pharma GmbH - Overview
              • Exhibit 139: Covis Pharma GmbH - Product / Service
              • Exhibit 140: Covis Pharma GmbH - Key offerings
            • 12.7 GE Healthcare Technologies Inc.
              • Exhibit 141: GE Healthcare Technologies Inc. - Overview
              • Exhibit 142: GE Healthcare Technologies Inc. - Business segments
              • Exhibit 143: GE Healthcare Technologies Inc. - Key offerings
              • Exhibit 144: GE Healthcare Technologies Inc. - Segment focus
            • 12.8 Guerbet
              • Exhibit 145: Guerbet - Overview
              • Exhibit 146: Guerbet - Product / Service
              • Exhibit 147: Guerbet - Key offerings
            • 12.9 iMAX Diagnostic Imaging Ltd.
              • Exhibit 148: iMAX Diagnostic Imaging Ltd. - Overview
              • Exhibit 149: iMAX Diagnostic Imaging Ltd. - Product / Service
              • Exhibit 150: iMAX Diagnostic Imaging Ltd. - Key offerings
            • 12.10 Interpharma Praha as
              • Exhibit 151: Interpharma Praha as - Overview
              • Exhibit 152: Interpharma Praha as - Product / Service
              • Exhibit 153: Interpharma Praha as - Key offerings
            • 12.11 Jodas Expoim Pvt. Ltd.
              • Exhibit 154: Jodas Expoim Pvt. Ltd. - Overview
              • Exhibit 155: Jodas Expoim Pvt. Ltd. - Product / Service
              • Exhibit 156: Jodas Expoim Pvt. Ltd. - Key offerings
            • 12.12 Lantheus Holdings Inc.
              • Exhibit 157: Lantheus Holdings Inc. - Overview
              • Exhibit 158: Lantheus Holdings Inc. - Business segments
              • Exhibit 159: Lantheus Holdings Inc. - Key offerings
              • Exhibit 160: Lantheus Holdings Inc. - Segment focus
            • 12.13 Livealth Biopharma Pvt. Ltd.
              • Exhibit 161: Livealth Biopharma Pvt. Ltd. - Overview
              • Exhibit 162: Livealth Biopharma Pvt. Ltd. - Product / Service
              • Exhibit 163: Livealth Biopharma Pvt. Ltd. - Key offerings
            • 12.14 M.Biotech Ltd.
              • Exhibit 164: M.Biotech Ltd. - Overview
              • Exhibit 165: M.Biotech Ltd. - Product / Service
              • Exhibit 166: M.Biotech Ltd. - Key offerings
            • 12.15 Nano Therapeutics Pvt. Ltd.
              • Exhibit 167: Nano Therapeutics Pvt. Ltd. - Overview
              • Exhibit 168: Nano Therapeutics Pvt. Ltd. - Product / Service
              • Exhibit 169: Nano Therapeutics Pvt. Ltd. - Key offerings
            • 12.16 Spago Nanomedical AB
              • Exhibit 170: Spago Nanomedical AB - Overview
              • Exhibit 171: Spago Nanomedical AB - Product / Service
              • Exhibit 172: Spago Nanomedical AB - Key offerings
            • 12.17 Taejoon Pharm Co. Ltd.
              • Exhibit 173: Taejoon Pharm Co. Ltd. - Overview
              • Exhibit 174: Taejoon Pharm Co. Ltd. - Product / Service
              • Exhibit 175: Taejoon Pharm Co. Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 176: Inclusions checklist
                • Exhibit 177: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 178: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 179: Research methodology
                • Exhibit 180: Validation techniques employed for market sizing
                • Exhibit 181: Information sources
              • 13.5 List of abbreviations
                • Exhibit 182: List of abbreviations
              • application:

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                PURCHASE FULL REPORT OF

                contrast media market market

                QUICK BUY

                Key Questions Answered

                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?

                Why should you prefer Technavio's market insights report?

                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis